The genetic basis of inhibitor development in haemophilia A
- PMID: 9873791
- DOI: 10.1046/j.1365-2516.1998.440543.x
The genetic basis of inhibitor development in haemophilia A
Abstract
Inhibitor development is now the main complication of replacement therapy in haemophilia A. Given that most severely affected patients make no detectable factor VIII, it is perhaps surprising that only approximately 30% actually mount an immune response to factor VIII as a foreign antigen. Those that do mostly have major factor VIII gene lesions. The association of HLA genotype with inhibitors in patients with identical mutations is weak. Environmental factors may be more important than genetic in antibody response to factor VIII.
Similar articles
-
Histocompatibility antigens and alleles in Japanese haemophilia A patients with or without factor VIII antibodies.Tissue Antigens. 1999 Jul;54(1):91-7. doi: 10.1034/j.1399-0039.1999.540111.x. Tissue Antigens. 1999. PMID: 10458328
-
Factor VIII inhibitors in mild and moderate-severity haemophilia A.Haemophilia. 1998 Jul;4(4):558-63. doi: 10.1046/j.1365-2516.1998.440558.x. Haemophilia. 1998. PMID: 9873794 Review.
-
Inhibitor development in correlation to factor VIII genotypes.Haemophilia. 2002 Mar;8 Suppl 2:23-9. doi: 10.1046/j.1351-8216.2001.00134.x. Haemophilia. 2002. PMID: 11966849 Review.
-
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A.Hamostaseologie. 2008 Oct;28 Suppl 1:S26-8. Hamostaseologie. 2008. PMID: 18958335
-
Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A.Haematologica. 2019 Mar;104(3):599-608. doi: 10.3324/haematol.2018.195669. Epub 2018 Sep 28. Haematologica. 2019. PMID: 30266735 Free PMC article.
Cited by
-
Haemophilia A and haemophilia B: molecular insights.Mol Pathol. 2002 Apr;55(2):127-44. doi: 10.1136/mp.55.2.127. Mol Pathol. 2002. PMID: 11950963 Free PMC article. Review.
-
Haemophilia A and haemophilia B: molecular insights.Mol Pathol. 2002 Feb;55(1):1-18. doi: 10.1136/mp.55.1.1. Mol Pathol. 2002. Corrected and republished in: Mol Pathol. 2002 Apr;55(2):127-44. doi: 10.1136/mp.55.2.127. PMID: 11836440 Free PMC article. Corrected and republished. Review.
-
Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.J Thromb Haemost. 2016 Feb;14(2):346-55. doi: 10.1111/jth.13202. Epub 2016 Jan 8. J Thromb Haemost. 2016. PMID: 26588198 Free PMC article.
-
The Association Between HLA Class II Alleles and the Occurrence of Factor VIII Inhibitor in Thai Patients with Hemophilia A.Turk J Haematol. 2012 Mar;29(1):34-9. doi: 10.5505/tjh.2012.29795. Epub 2012 Mar 5. Turk J Haematol. 2012. PMID: 24744621 Free PMC article.
-
Blood Clotting Factor VIII: From Evolution to Therapy.Acta Naturae. 2013 Apr;5(2):19-39. Acta Naturae. 2013. PMID: 23819034 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials